Boardroom Alpha
Boardroom Alpha
GRDN · Additional Proxy Materials (DEFA14A) · Filed March 26, 2026

Guardian Pharmacy Services Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 26, 2026
Ticker
GRDN
Accession
0001193125-26-125073
Boardroom Alpha · Filing insights

Guardian Pharmacy Services, Inc. board urges 'FOR' on all nominees and key proposals at the 2026 annual meeting.

About Guardian Pharmacy Services Inc
Market cap
$2.5B
1Y TSR
+80.4%
Board grade
A-
Sector
Healthcare
CEO
Fred Burke
Last annual meeting: May 5, 2026 · View full Guardian Pharmacy Services Inc profile →
DEFA14A
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

 

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Pursuant to § 240.14a-12

Guardian Pharmacy Services, Inc.

(Name of Registrant as Specified in Its Charter)

N/A

(Name of Person(s) Filing Proxy Statement if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

No fee required.

 

Fee paid previously with preliminary materials.

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 
 


LOGO

 

  P.O. BOX 8016, CARY, NC 27512-9903

 

 

LOGO

 

  LOGO

 

 

Guardian Pharmacy Services, Inc.

 

Annual Meeting of Stockholders

 

Tuesday, May 5, 2026 1:00 PM, Eastern Time

 

8909 Purdue Road, Suite 500, Indianapolis, IN 46268

 

For a convenient way to view proxy materials, VOTE, and obtain directions to attend the meeting go to www.proxydocs.com/GRDN

 

To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.

 

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the Internet.

 

If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before April 24, 2026.

  

LOGO

 

 

 

Meeting Materials: Notice of Meeting and Proxy Statement & Annual Report on Form 10-K

 

Important Notice Regarding the Availability of Proxy Materials for the Stockholders Meeting To Be Held On May 5, 2026 For Stockholders of record as of March 13, 2026

 

To order paper materials, use one of the following methods.

 

LOGO

 

Internet:

www.investorelections.com/GRDN

 

LOGO

Call:

1-866-648-8133

 

LOGO

Email:

paper@investorelections.com

 

* If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material.

 

LOGO         

    

Have the 12 digit control number located in the box above available when you access the website and follow the instructions.

SEE REVERSE FOR FULL AGENDA     

Copyright © 2026 BetaNXT, Inc. or its affiliates. All Rights Reserved    


LOGO    Guardian Pharmacy Services, Inc. Annual Meeting of Stockholders

THE BOARD OF DIRECTORS RECOMMENDS A VOTE:

FOR each of the nominees listed in PROPOSAL 1, FOR PROPOSALS 2 and 4 and for 1 YEAR on PROPOSAL 3.

 

 

 

PROPOSAL

 

 

1.    To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified.   
   1.01 John Ackerman   
   1.02 Randall Lewis   
2.    To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers.   
3.    To approve, on a non-binding advisory basis, the frequency of the Company’s future advisory votes to approve the compensation of the Company’s named executive officers.   
4.    To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026.   
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Guardian Pharmacy Services Inc (GRDN)

Reference

Frequently asked questions

When did Guardian Pharmacy Services Inc file this DEFA14A?
Guardian Pharmacy Services Inc (GRDN) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 26, 2026. The accession number assigned by EDGAR is 0001193125-26-125073.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Guardian Pharmacy Services, Inc. board urges 'FOR' on all nominees and key proposals at the 2026 annual meeting. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Guardian Pharmacy Services Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Guardian Pharmacy Services Inc has filed under CIK 1802255, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer